Amprologix presents at AMR conference in Basel
28 February 2025Mat Upton, CSO, presented new data at the 9th AMR conference in Basel on 25th February. It was suggested that…
Mat Upton, CSO, presented new data at the 9th AMR conference in Basel on 25th February. It was suggested that…
Amprologix will be attending the Investival Showcase in London on 18th November 2024 Amprologix will be attending the Investival Showcase in…
Amprologix files the first of a new series of patents protecting novel molecular structures for the treatment of bacterial infections.…
Innovate UK has awarded Amprologix £1M of Biomedical Catalyst funding to continue the Tobraderm project 1st March 2024 Amprologix is…
October 2022 CSO Mat Upton joined 19 other start-ups that were selected from 700 applicants for a place at the…
Amprologix CSO collaborates with Dr Max Ryadnov from the UK’s National Physical Laboratory, to publish new data on the novel mode of action of epidermicin NI01. Findings are reported in the August issue of iScience.
